OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
Auteurs principaux: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Publié: |
BMJ Publishing Group
2017
|